Literature DB >> 1376156

Infections and pseudoinfections due to povidone-iodine solution contaminated with Pseudomonas cepacia.

A L Panlilio1, C M Beck-Sague, J D Siegel, R L Anderson, S Y Yetts, N C Clark, P N Duer, K A Thomassen, R W Vess, B C Hill.   

Abstract

In 1989 we investigated the first instance of Pseudomonas cepacia infections due to intrinsic contamination of a povidone-iodine product. Six patients in a Texas pediatric facility had P. cepacia infection or pseudoinfection (three, peritonitis; one, pseudoperitonitis; and two, pseudobacteremia). Epidemiological studies showed one risk factor for infection of peritoneal fluid with P. cepacia: performance of peritoneal dialysis in the dialysis unit with use of one lot of povidone-iodine later found to be intrinsically contaminated (4/5 vs. 0/16, P = .001). Blood cultures yielded P. cepacia after nurses wiped the tops of blood culture bottles with the povidone-iodine solution before inoculation. P. cepacia was cultured from three povidone-iodine containers used at the hospital and from four containers of the same lot obtained from other health-care facilities in Texas and California. Isolates from patients and the povidone-iodine had similar antibiograms, identical plasmid profiles, and identical DNA banding patterns on the basis of results of ribonucleotide typing. This investigation demonstrates that intrinsic contamination of povidone-iodine solution with P. cepacia can result in infections in addition to colonization and/or pseudoinfection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376156     DOI: 10.1093/clinids/14.5.1078

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review.

Authors:  Josie Chundamala; James G Wright
Journal:  Can J Surg       Date:  2007-12       Impact factor: 2.089

Review 2.  Outbreaks associated with contaminated antiseptics and disinfectants.

Authors:  David J Weber; William A Rutala; Emily E Sickbert-Bennett
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

3.  Liquid-infused structured surfaces with exceptional anti-biofouling performance.

Authors:  Alexander K Epstein; Tak-Sing Wong; Rebecca A Belisle; Emily Marie Boggs; Joanna Aizenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

Review 4.  Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.

Authors:  E H Bingen; E Denamur; J Elion
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration.

Authors:  Alexander K Epstein; Boaz Pokroy; Agnese Seminara; Joanna Aizenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-29       Impact factor: 11.205

7.  Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers.

Authors:  C Doit; C Loukil; A-M Simon; A Ferroni; J-E Fontan; S Bonacorsi; P Bidet; V Jarlier; Y Aujard; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Cluster of Enterobacter cloacae pseudobacteremias associated with use of an agar slant blood culturing system.

Authors:  M L Pearson; D A Pegues; L A Carson; R O'Donnell; R H Berger; R L Anderson; W R Jarvis
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia).

Authors:  Bindu M Nair; K-John Cheung; Adam Griffith; Jane L Burns
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.